Literature DB >> 17940039

HOXB4's road map to stem cell expansion.

Bernhard Schiedlmeier1, Ana Cristina Santos, Ana Ribeiro, Natalia Moncaut, Dietrich Lesinski, Herbert Auer, Karl Kornacker, Wolfram Ostertag, Christopher Baum, Moises Mallo, Hannes Klump.   

Abstract

Homeodomain-containing transcription factors are important regulators of stem cell behavior. HOXB4 mediates expansion of adult and embryo-derived hematopoietic stem cells (HSCs) when expressed ectopically. To define the underlying molecular mechanisms, we performed gene expression profiling in combination with subsequent functional analysis with enriched adult HSCs and embryonic derivatives expressing inducible HOXB4. Thereby, we identified a set of overlapping genes that likely represent "universal" targets of HOXB4. A substantial number of loci are involved in signaling pathways important for controlling self-renewal, maintenance, and differentiation of stem cells. Functional assays performed on selected pathways confirmed the biological coherence of the array results. HOXB4 activity protected adult HSCs from the detrimental effects mediated by the proinflammatory cytokine TNF-alpha. This protection likely contributes to the competitive repopulation advantage of HOXB4-expressing HSCs observed in vivo. The concept of TNF-alpha inhibition may also prove beneficial for patients undergoing bone marrow transplantation. Furthermore, we demonstrate that HOXB4 activity and FGF signaling are intertwined. HOXB4-mediated expansion of adult and ES cell-derived HSCs was enhanced by specific and complete inhibition of FGF receptors. In contrast, the expanding activity of HOXB4 on hematopoietic progenitors in day 4-6 embryoid bodies was blunted in the presence of basic FGF (FGF2), indicating a dominant negative effect of FGF signaling on the earliest hematopoietic cells. In summary, our results strongly suggest that HOXB4 modulates the response of HSCs to multiple extrinsic signals in a concerted manner, thereby shifting the balance toward stem cell self-renewal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940039      PMCID: PMC2040480          DOI: 10.1073/pnas.0703082104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance.

Authors:  Andrew W Duncan; Frédérique M Rattis; Leah N DiMascio; Kendra L Congdon; Gregory Pazianos; Chen Zhao; Keejung Yoon; J Michael Cook; Karl Willert; Nicholas Gaiano; Tannishtha Reya
Journal:  Nat Immunol       Date:  2005-01-23       Impact factor: 25.606

Review 2.  Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling.

Authors:  Jacqueline M Mason; Debra J Morrison; M Albert Basson; Jonathan D Licht
Journal:  Trends Cell Biol       Date:  2005-12-07       Impact factor: 20.808

3.  HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cues.

Authors:  Elke Will; Daniel Speidel; Zheng Wang; Gabriel Ghiaur; Andreas Rimek; Bernhard Schiedlmeier; David A Williams; Christopher Baum; Wolfram Ostertag; Hannes Klump
Journal:  Cell Cycle       Date:  2006-01-09       Impact factor: 4.534

4.  Negative regulation of primitive hematopoiesis by the FGF signaling pathway.

Authors:  Fumie Nakazawa; Hiroki Nagai; Masahiro Shin; Guojun Sheng
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

5.  Smad7 promotes self-renewal of hematopoietic stem cells.

Authors:  Ulrika Blank; Goran Karlsson; Jennifer L Moody; Taiju Utsugisawa; Mattias Magnusson; Sofie Singbrant; Jonas Larsson; Stefan Karlsson
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

6.  Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation.

Authors:  Changwon Park; Kory Lavine; Yuji Mishina; Chu-Xia Deng; David M Ornitz; Kyunghee Choi
Journal:  Development       Date:  2006-08-03       Impact factor: 6.868

7.  Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells.

Authors:  Colleen Delaney; Barbara Varnum-Finney; Keisuke Aoyama; Carolyn Brashem-Stein; Irwin D Bernstein
Journal:  Blood       Date:  2005-06-23       Impact factor: 22.113

8.  NARF, an nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF).

Authors:  Misato Yamada; Junji Ohnishi; Bisei Ohkawara; Shunichiro Iemura; Kiyotoshi Satoh; Junko Hyodo-Miura; Kaoru Kawachi; Tohru Natsume; Hiroshi Shibuya
Journal:  J Biol Chem       Date:  2006-05-19       Impact factor: 5.157

9.  Nrarp functions to modulate neural-crest-cell differentiation by regulating LEF1 protein stability.

Authors:  Tohru Ishitani; Kunihiro Matsumoto; Ajay B Chitnis; Motoyuki Itoh
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

10.  FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.

Authors:  Zuzana Tothova; Ramya Kollipara; Brian J Huntly; Benjamin H Lee; Diego H Castrillon; Dana E Cullen; Elizabeth P McDowell; Suzan Lazo-Kallanian; Ifor R Williams; Christopher Sears; Scott A Armstrong; Emmanuelle Passegué; Ronald A DePinho; D Gary Gilliland
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

View more
  36 in total

1.  Ex vivo expansion of cord blood progenitors impairs their short-term and long-term repopulating activity associated with transcriptional dysregulation of signalling networks.

Authors:  T Holmes; F Yan; K-H Ko; R Nordon; E Song; T A O'Brien; A Dolnikov
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

2.  Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Authors:  Rong Fan; Sabrina Bonde; Peng Gao; Brendan Sotomayor; Changya Chen; Tyler Mouw; Nicholas Zavazava; Kai Tan
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

3.  Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential.

Authors:  Yoshinori Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Sayaka Mori; Miyuki Tsumura; Satoshi Okada; Tomohiko Ohta; Kiyoshi Ohtani; Masao Kobayashi; Yoshihiro Takihara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Cytokines regulating hematopoietic stem cell function.

Authors:  Cheng C Zhang; Harvey F Lodish
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

5.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Authors:  Motohiko Oshima; Mitsuhiro Endoh; Takaho A Endo; Tetsuro Toyoda; Yaeko Nakajima-Takagi; Fumihiro Sugiyama; Haruhiko Koseki; Michael Kyba; Atsushi Iwama; Mitsujiro Osawa
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

6.  Induction of hematopoietic differentiation of mouse embryonic stem cells by an AGM-derived stromal cell line is not further enhanced by overexpression of HOXB4.

Authors:  Sabrina A M Gordon-Keylock; Melany Jackson; Caoxin Huang; Kay Samuel; Richard A Axton; Robert A J Oostendorp; Helen Taylor; Julie Wilson; Lesley M Forrester
Journal:  Stem Cells Dev       Date:  2010-09-09       Impact factor: 3.272

7.  HOXA4 provides stronger engraftment potential to short-term repopulating cells than HOXB4.

Authors:  Marilaine Fournier; Charles-Étienne Lebert-Ghali; Janetta J Bijl
Journal:  Stem Cells Dev       Date:  2015-08-12       Impact factor: 3.272

8.  HOXB4 Increases Runx1 Expression to Promote the de novo Formation of Multipotent Hematopoietic Cells.

Authors:  Nadine Teichweyde; Peter A Horn; Hannes Klump
Journal:  Transfus Med Hemother       Date:  2017-05-19       Impact factor: 3.747

9.  Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.

Authors:  Michael D Milsom; Bernhard Schiedlmeier; Jeff Bailey; Mi-Ok Kim; Dandan Li; Michael Jansen; Abdullah Mahmood Ali; Michelle Kirby; Christopher Baum; Leslie J Fairbairn; David A Williams
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

10.  Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.

Authors:  Hui Yu; Geoffrey Neale; Hui Zhang; Han M Lee; Zhijun Ma; Sheng Zhou; Bernard G Forget; Brian P Sorrentino
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.